Education
About Us
Working with TipRanks
Follow Us
Richard Dennis Insider Profile
4 Followers
Richard Dennis, Chief Commercial Officer at Proteome Sciences, holds 2.05M shares in Proteome Sciences (Ticker: GB:PRM). Most recently, Richard Dennis Bought 1,428,571 shares of Proteome Sciences on Jan 26, 2026 for an estimated value of 25.00K .
Richard Dennis Proteome Sciences (PRM)Chief Commercial Officer
Proteome Sciences (PRM)
Chief Commercial Officer
Ranked #69,396 out of 106,324 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-17.40%
Average return per transaction
Time Frame
Compare to
Insider Roles
Chief Commercial Officer
Roles that Richard Dennis holds in companies
Most Profitable Insider Trade
The most profitable trade made by Richard Dennis
Richard Dennis's Trading History
List of latest transactions for each holding click on a transaction to see Richard Dennis's performance on stock
You May Also Like
Richard Dennis insider profile FAQ
What is the percentage of profitable transactions made by Richard Dennis?
The percentage of profitable transactions made by Richard Dennis is 0%.
What is the average return per transaction made by Richard Dennis?
The average return per transaction made by Richard Dennis is -17.40%.
What stocks does Richard Dennis hold?
Richard Dennis holds: GB:PRM stocks.
What was Richard Dennis’s latest transaction?
Richard Dennis latest transaction was an Informative Buy of 25.00K .
What was Richard Dennis's most profitable transaction?
Richard Dennis’s most profitable transaction was an Informative Buy of GB:PRM stock on January 26, 2026. The return on the trade was -8.10%.
What is Richard Dennis's role in Proteome Sciences?
Richard Dennis's role in Proteome Sciences is Chief Commercial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.